KOE:196170

Alteogen Inc. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:40 UTC

Last close

n/aKRW

Market data

  • 75.6xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 65.6%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 46.9%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed

Then and now

lens 3 of 9
Five filed facts, 2014 against 2025.
Fact20142025Change
Sales7,042,577,910215,858,919,000+2,965%
Profit931,144,490141,666,025,000+15,114%
Free cash flow1,177,497,420101,120,550,000+8,488%
Debtn/a100,798,982,000n/a
Shares in issue31,475,34253,506,000+70.0%

The same five facts for 2014 and 2025, each read from the year's own filing.

The same five facts for 2014 and 2025, each read from the year's own filing.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2014

  • Sales, 20147,042,577,910
    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    KRW
  • Sales, 2025215,858,919,000Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Profit, 2014931,144,490
    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    KRW
  • Profit, 2025141,666,025,000Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Free cash flow, 20141,177,497,420
    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    KRW
  • Free cash flow, 2025101,120,550,000Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Debt, 2014n/a

    Not held.

    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    KRW
  • Debt, 2025100,798,982,000Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Shares in issue, 201431,475,342
    Source
    computed
    Statement
    income
    Fiscal year
    2014
    Reported in
    KRW
  • Shares in issue, 202553,506,000Computed from the filing for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.